Company: CERO
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-044335
Chunk: 251

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 1A
Chunk 251
---
 of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    32.2^
     
    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    101.INS*
     
    Inline
    XBRL Instance Document

    101.SCH*
     
    Inline
    XBRL Taxonomy Extension Schema Document

    101.CAL*
     
    Inline
    XBRL Taxonomy Extension Calculation Linkbase Document

    101.DEF*
     
    Inline
    XBRL Taxonomy Extension Definition Linkbase Document

    101.LAB*
     
    Inline
    XBRL Taxonomy Extension Labels Linkbase Document

    101.PRE*
     
    Inline
    XBRL Taxonomy Extension Presentation Linkbase Document

    104
     
    Cover
    Page Interactive Data File-the cover page interactive data is embedded within the Inline XBRL document or included within the Exhibit
    101 attachments.

    *
    Filed herewith.

    ^
    Furnished herewith.

    +
    Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.

    †
    Certain portions of this document that constitute confidential information have been redacted pursuant to Item 601(b)(10) of Regulation S-K.

43

SIGNATURES

In accordance with the requirements of the Exchange
Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    CERO THERAPEUTICS HOLDINGS, INC.

    Date: May 15, 2025
    By:
    /s/ Chris Ehrlich

    Name: 
    Chris Ehrlich

    Title:
    Interim Chairman and Chief Executive Officer

    (Principal Executive Officer)

    Date May 15, 2025
    By:
    /s/ Andrew Kucharchuk

    Name:
    Andrew Kucharchuk

    Title:
    Chief Financial Officer

    (Principal Financial and Accounting Officer)

44

P5Y
P5Y

30000
0001870404